Dominick Colangelo

CIK: 0001313403

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)12 (27.3%)

Position reduction

Option Exercises (M)20 (45.5%)

Derivative conversions

Awards (A)7 (15.9%)

Compensation grants

Other (G, F, J, C, D, …)5 (11.4%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

TRVI

Trevi Therapeutics, Inc.

Director

VCEL

Vericel Corp

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (44 total)

TRVI
Trevi Therapeutics, Inc.
Jun 3, 2026
Award(A)
Nonstatutory Stock Option (right to buy)
Direct
35K shares-
VCEL
Vericel Corp
Feb 24, 2026
Tax Payment(F)
Direct
8.8K shares at avg. $38.09$336K
VCEL
Vericel Corp
Feb 24, 2026
Exercise(M)
Direct
18.3K shares-
VCEL
Vericel Corp
Feb 24, 2026
Exercise(M)
Direct
18.3K shares-
VCEL
Vericel Corp
Feb 19, 2026
Award(A)
Restricted Stock Unit
Direct
73K shares-
VCEL
Vericel Corp
Feb 19, 2026
Award(A)
Stock Option (Right to Buy)
Direct
182.5K shares-
VCEL
Vericel Corp
Feb 18, 2026
Exercise(M)
Direct
11.7K shares-
VCEL
Vericel Corp
Feb 18, 2026
Exercise(M)
Direct
18.3K shares-
VCEL
Vericel Corp
Feb 18, 2026
Tax Payment(F)
Direct
5.7K shares at avg. $37.41$212K
VCEL
Vericel Corp
Jun 30, 2025
Award(A)
Direct
123 shares at avg. $36.17$4K
TRVI
Trevi Therapeutics, Inc.
Jun 11, 2025
Award(A)
Nonstatutory Stock Option (right to buy)
Direct
45K shares-
VCEL
Vericel Corp
May 15, 2025
Sale(S)
Direct
14.1K shares at avg. $41.53$584K
VCEL
Vericel Corp
May 15, 2025
Exercise(M)
Direct
14.1K shares at avg. $2.65$37K
VCEL
Vericel Corp
May 14, 2025
Exercise(M)
Direct
14.1K shares at avg. $2.65$37K
VCEL
Vericel Corp
May 14, 2025
Sale(S)
Direct
14.1K shares at avg. $42.25$594K
VCEL
Vericel Corp
Apr 10, 2025
Exercise(M)
Direct
24.9K shares at avg. $2.75$68K
VCEL
Vericel Corp
Apr 10, 2025
Sale(S)
Direct
24.9K shares at avg. $41.89$1.0M
VCEL
Vericel Corp
Apr 9, 2025
Sale(S)
Direct
24.9K shares at avg. $41.11$1.0M
VCEL
Vericel Corp
Apr 9, 2025
Exercise(M)
Direct
24.9K shares at avg. $2.75$68K
VCEL
Vericel Corp
Mar 13, 2025
Exercise(M)
Direct
26.6K shares at avg. $1.95$52K
VCEL
Vericel Corp
Mar 13, 2025
Sale(S)
Direct
26.6K shares at avg. $45.78$1.2M
VCEL
Vericel Corp
Mar 12, 2025
Exercise(M)
Direct
26.6K shares at avg. $1.95$52K
VCEL
Vericel Corp
Mar 12, 2025
Sale(S)
Direct
26.6K shares at avg. $46.31$1.2M
VCEL
Vericel Corp
Feb 24, 2025
Exercise(M)
Direct
18.3K shares-
VCEL
Vericel Corp
Feb 24, 2025
Tax Payment(F)
Direct
8.5K shares at avg. $52.33$443K

		Type	Shares	Price		Ownership
Jun 3, 2026	TRVI Trevi Therapeutics, Inc.	Award(A) Nonstatutory Stock Option (right to buy)	35,000	-	-	Direct
Feb 24, 2026	VCEL Vericel Corp	Tax Payment(F)	8,824	$38.09	$336,106	Direct
Feb 24, 2026	VCEL Vericel Corp	Exercise(M)	18,250	-	$0	Direct
Feb 24, 2026	VCEL Vericel Corp	Exercise(M)	18,250	-	$0	Direct
Feb 19, 2026	VCEL Vericel Corp	Award(A) Restricted Stock Unit	73,000	-	-	Direct
Feb 19, 2026	VCEL Vericel Corp	Award(A) Stock Option (Right to Buy)	182,500	-	-	Direct
Feb 18, 2026	VCEL Vericel Corp	Exercise(M)	11,700	-	$0	Direct
Feb 18, 2026	VCEL Vericel Corp	Exercise(M)	18,250	-	$0	Direct
Feb 18, 2026	VCEL Vericel Corp	Tax Payment(F)	5,657	$37.41	$211,628	Direct
Jun 30, 2025	VCEL Vericel Corp	Award(A)	123	$36.17	$4,449	Direct
Jun 11, 2025	TRVI Trevi Therapeutics, Inc.	Award(A) Nonstatutory Stock Option (right to buy)	45,000	-	-	Direct
May 15, 2025	VCEL Vericel Corp	Sale(S)	14,063	$41.53	$584,036	Direct
May 15, 2025	VCEL Vericel Corp	Exercise(M)	14,063	$2.65	$37,267	Direct
May 14, 2025	VCEL Vericel Corp	Exercise(M)	14,062	$2.65	$37,264	Direct
May 14, 2025	VCEL Vericel Corp	Sale(S)	14,062	$42.25	$594,120	Direct
Apr 10, 2025	VCEL Vericel Corp	Exercise(M)	24,850	$2.75	$68,338	Direct
Apr 10, 2025	VCEL Vericel Corp	Sale(S)	24,850	$41.89	$1,040,967	Direct
Apr 9, 2025	VCEL Vericel Corp	Sale(S)	24,850	$41.11	$1,021,584	Direct
Apr 9, 2025	VCEL Vericel Corp	Exercise(M)	24,850	$2.75	$68,338	Direct
Mar 13, 2025	VCEL Vericel Corp	Exercise(M)	26,592	$1.95	$51,854	Direct
Mar 13, 2025	VCEL Vericel Corp	Sale(S)	26,592	$45.78	$1,217,382	Direct
Mar 12, 2025	VCEL Vericel Corp	Exercise(M)	26,591	$1.95	$51,852	Direct
Mar 12, 2025	VCEL Vericel Corp	Sale(S)	26,591	$46.31	$1,231,429	Direct
Feb 24, 2025	VCEL Vericel Corp	Exercise(M)	18,250	-	-	Direct
Feb 24, 2025	VCEL Vericel Corp	Tax Payment(F)	8,459	$52.33	$442,659	Direct

1-25 of 44 transactions

About Colangelo Dominick

Colangelo Dominick (SEC CIK 0001313403) files insider reports with the SEC as Director of Trevi Therapeutics, Inc. (TRVI) and President and CEO of Vericel Corp (VCEL).

Signal8 holds 14 ownership filings by Colangelo Dominick (13 Form 4, 1 Form 5), filed between Sep 13, 2024 and Jun 4, 2026. Those filings report 44 transactions, from Sep 11, 2024 to Jun 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Colangelo Dominick's filings is in CAMBRIDGE, MA.

Recent filings by Colangelo Dominick

Jun 3, 2026: Grant or award of TRVI derivative securities (Form 4, code A).
Feb 24, 2026: Tax withholding of VCEL shares (Form 4, code F).
Feb 24, 2026: Option exercises of VCEL shares (2 lines, Form 4, code M).
Feb 19, 2026: Grants or awards of VCEL derivative securities (2 lines, Form 4, code A).
Feb 18, 2026: Option exercises of VCEL shares (2 lines, Form 4, code M).

Other insiders filing for Trevi Therapeutics, Inc. (TRVI)

Heffernan Michael Thomas, Director
Mathers Edward T, Director
Meeker David P, Director
VANLENT ANNE, Director
Cassella James V, Chief Development Officer
Galletta Christopher

How to read Form 4 transaction codes